Campbell, Ca., November 20, 2006 - Hunter Labs' New HPV Test Offers Advantages Over Other Laboratories
Hunter Laboratories, Inc.'s new Human Papillomavirus (HPV) DNA testing methodology offers advantages over all other laboratories in Northern California.

Hunter's methodology is the Invader® Molecular HPV assay from Third Wave Technologies.  Studies in several major medical centers have demonstrated that it reduces the occurrences of false negatives, detects mixed infections with multiple HPV types and increases specificity.

The Invader assay reduces the occurence of false negatives by monitoring DNA extraction and sample adequacy by inclusion of an internal control.  The control evaluates the quantity of cellular DNA content using the human alpha-actin gene.

Mixed infections with multiple HPV types are easily detected by the Invader assay by using a unmatched three probe pools. 

Research has conclusively demonstrated that HPV, particularly high-risk types, is implicated in virtually all cervical cancer.  As a result, HPV DNA testing is recommended in cervical cancer screening guidelines as an adjunt to cytology screening.

The American College of Obstetricians and Gynecologists and the American Cancer Society both recommend "high risk" HPV testing in conjunction with a PAP test for all women age 30 or older at least every three years.

Related Outside Articles
Human Papillomavirus in Atypical Squamous Cervical Cytology: The Invader HPV Test as a New Screening Assay


Test Order Codes
4450 HPV High Risk
1826 SurePath PAP with HPV
1821 SurePath PAP, relfex HPV on ASC-US & above
1822 SurePath PAP, reflex on ASC-US only
8130 Thin Prep PAP with HPV
8110 Thin Prep PAP, reflex HPV on ASC-US & above
8120 Thin Prep PAP, reflex on ASC-US only